Argenx to participate in upcoming virtual investor conferences

November 9, 2020 breda, the netherlands / ghent, belgium – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that management will participate in several upcoming investor conferences:

ARGX Ratings Summary

ARGX Quant Ranking